Pfizer Inc.'s ( PFE) ABRILADA, a biosimilar to Humira, has received FDA approval for the treatment of certain patients with rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, ulcerative colitis and plaque psoriasis.
from RTT - Biotech https://ift.tt/2CSsZ2P
via IFTTT
No comments:
Post a Comment